Aspirin Given for Up to 2 Years After Initial Anticoagulant Treatment Reduces the Risk of Venous Thromboembolism Recurrence Without Increasing Risk of Major Bleeding

Evidence-based nursing - United Kingdom
doi 10.1136/eb-2012-100896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Risk Factors for Venous Thromboembolism After Hysterectomy

Obstetrics and Gynecology
GynecologyObstetrics
2015English

Treatment of Venous Thromboembolism – Effects of Different Therapeutic Strategies on Bleeding and Recurrence Rates and Considerations for Future Anticoagulant Management

Thrombosis Journal
Hematology
2012English

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders
SurgeryCardiovascular MedicineCardiology
2017English

The Risk of Venous Thromboembolism in Patients With Clinically Overt Gastrointestinal Bleeding

American Journal of Hematology
Hematology
2017English

A Descriptive Analysis of Patient Characteristics, Bleeding and Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous Thromboembolism

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Identifying Patients at High Risk for Venous Thromboembolism Requiring Treatment After Outpatient Surgery

Annals of Surgery
Surgery
2012English

Identifying Risk Factors for Venous Thromboembolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

New Risk Factor for Venous Thromboembolism?

Thrombosis and Haemostasis
Hematology
2008English

A Risk Score for Prediction of Recurrence in Patients With Unprovoked Venous Thromboembolism (DAMOVES)

European Journal of Internal Medicine
Internal Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy